Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 1
1985 1
1986 1
1991 2
1992 2
1994 2
1995 2
1996 2
1997 1
1998 2
1999 5
2000 1
2002 6
2003 1
2005 4
2006 1
2007 7
2008 3
2009 6
2010 5
2011 2
2012 4
2013 3
2014 7
2015 5
2016 2
2017 4
2018 6
2019 7
2020 6
2021 6
2022 4
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Silent somatotropinomas.
Lamas C, García-Martínez A, Cámara R, Fajardo-Montanana C, Viguera L, Aranda I. Lamas C, et al. Among authors: aranda i. Minerva Endocrinol. 2019 Jun;44(2):137-142. doi: 10.23736/S0391-1977.18.02946-2. Epub 2018 Dec 7. Minerva Endocrinol. 2019. PMID: 30531696 Review.
Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Carbonero R, Vilardell F, Jiménez-Fonseca P, González-Campora R, González E, Cuatrecasas M, Capdevila J, Aranda I, Barriuso J, Matías-Guiu X; Spanish Society of Pathology; Spanish Society of Medical Oncology. García-Carbonero R, et al. Among authors: aranda i. Clin Transl Oncol. 2014 Mar;16(3):243-56. doi: 10.1007/s12094-013-1062-9. Epub 2013 Jun 8. Clin Transl Oncol. 2014. PMID: 23749327
Pathological Findings Associated With SARS-CoV-2 on Postmortem Core Biopsies: Correlation With Clinical Presentation and Disease Course.
Ramos-Rincon JM, Herrera-García C, Silva-Ortega S, Portilla-Tamarit J, Alenda C, Jaime-Sanchez FA, Arenas-Jiménez J, Fornés-Riera FE, Scholz A, Escribano I, Pedrero-Castillo V, Muñoz-Miguelsanz C, Orts-Llinares P, Martí-Pastor A, Amo-Lozano A, García-Sevila R, Ribes-Mengual I, Moreno-Perez O, Concepcion-Aramendía L, Merino E, Sánchez-Martínez R, Aranda I. Ramos-Rincon JM, et al. Among authors: aranda i. Front Med (Lausanne). 2022 Jul 7;9:874307. doi: 10.3389/fmed.2022.874307. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35872778 Free PMC article.
Adjuvant docetaxel for high-risk, node-negative breast cancer.
Martín M, Seguí MA, Antón A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodríguez-Lescure A, Grosse R, Calvo L, Barnadas A, Isla D, Martinez del Prado P, Ruiz Borrego M, Zaluski J, Arcusa A, Muñoz M, López Vega JM, Mel JR, Munarriz B, Llorca C, Jara C, Alba E, Florián J, Li J, López García-Asenjo JA, Sáez A, Rios MJ, Almenar S, Peiró G, Lluch A; GEICAM 9805 Investigators. Martín M, et al. Among authors: aranda i. N Engl J Med. 2010 Dec 2;363(23):2200-10. doi: 10.1056/NEJMoa0910320. N Engl J Med. 2010. PMID: 21121833 Free article. Clinical Trial.
106 results